A platform to improve access and analysis of biomedical data for better health outcomes.
Official title: SysBio FAIRplex: a FAIR PLatform for EXploration of Systems Biology
Funded at Verily Life Sciences LLC · NIH-11090276 · Data updated 2026-11-12
The SysBio FAIRplex project is working on a new platform that makes it easier for researchers to access and use health data, especially for studying adult-onset diabetes, so they can work together and find better ways to improve health for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Verily Life Sciences LLC NIH-funded |
| Lab location | 1 site (South San Francisco, United States) |
| Project start | September 27, 2024 |
| Project end | September 26, 2025 |
| Funding year | 2024 |
| Award (this year) | $4,771,420 |
| NIH project number | 1OT2OD037975-01 |
| Project ID | NIH-11090276 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals with adult-onset diabetes and those interested in contributing to or benefiting from advancements in biomedical data analysis.
✕Less likely to help
Patients with conditions unrelated to adult-onset diabetes or those not engaged in research collaborations may not receive direct benefits from this research.
What this research studies
The SysBio FAIRplex project aims to create a platform that enhances the accessibility and usability of biomedical data from various sources. By integrating diverse datasets and providing advanced tools for analysis, this initiative seeks to empower researchers to derive meaningful insights that can lead to improved health outcomes. The platform will facilitate collaboration among researchers and enable the formation of larger virtual cohorts, thereby enhancing the scope and impact of biomedical research. Patients may benefit from the findings generated through this collaborative approach, which focuses on adult-onset diabetes and other health conditions.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in understanding and treating adult-onset diabetes and related health conditions.
How similar studies have gone: Other research initiatives have successfully utilized similar data integration and analysis approaches, indicating a promising potential for this novel platform.
Where this research is happening
-
Verily Life Sciences LLC
South San Francisco, United States Active
Researchers
- Principal investigator: Bookman, Matt — Verily Life Sciences LLC
- Study coordinator: Bookman, Matt
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.